Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
Drug Dev Ind Pharm ; 45(6): 995-998, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30892088

ABSTRACT

Novel fatty acid-bile acid conjugates (1a-1k) were designed and synthesized by coupling of the fatty acids to the 3-OH of bile acids using lysine for linkage. In the conjugates, the 24-COOH of the bile acids was kept intact to preserve liver-specific recognition. The ability of the newly synthesized conjugates (at 100 mg/kg dosage) to reduce total cholesterol (TC) and triglyceride (TG) levels in mice fed with high-fat diet (HFD) was evaluated. Conjugates of stearic acid with cholic acid and palmitic acid with ursodeoxycholic acid (at dosages of 50, 100, and 200 mg/kg) were further evaluated to determine their ability to reduce aspartate aminotransferase (AST), alanine aminotransferase (ALT), TC, and TG levels in mice fed with HFD. All conjugates showed potent hypolipidemic activity. Further investigation revealed that compounds 1c and 1 g not only dose-dependently reduced serum levels of TC and TG, but also inhibited the elevation of serum AST and ALT levels in mice fed with HFD. Thus, compounds 1c and 1 g are promising hypolipidemic agents with hepatocyte protective effects against HFD-induced liver damage.


Subject(s)
Bile Acids and Salts/administration & dosage , Fatty Acids/administration & dosage , Hyperlipidemias/drug therapy , Hypolipidemic Agents/administration & dosage , Liver/drug effects , Animals , Bile Acids and Salts/chemistry , Cholesterol/blood , Diet, High-Fat/adverse effects , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Fatty Acids/chemistry , Humans , Hyperlipidemias/blood , Hyperlipidemias/etiology , Hyperlipidemias/pathology , Hypolipidemic Agents/chemistry , Lipid Metabolism/drug effects , Liver/metabolism , Liver/pathology , Liver Function Tests , Lysine/chemistry , Mice , Triglycerides/blood
2.
Chemistry ; 24(51): 13549-13555, 2018 Sep 12.
Article in English | MEDLINE | ID: mdl-29952087

ABSTRACT

The first example of the synthesis of mono-N,O-B-chelated dipyrromethene (BODIPY) derivatives through an unexpected intramolecular nucleophilic displacement of the fluorine by alkenols in the presence of boron trifluoride as Lewis acid is reported. The chlorine in the indacene core allowed for further structural modifications through nucleophilic substitutions or palladium-catalysed coupling reactions to afford new fluorophores with tuneable photophysical properties. Their expanded conjugation structure resulted in distinct red-shifted absorption and emission spectra in organic solutions. Furthermore, the twisted steric hindrance of the benzene substitution patterns suppressed aggregation-induced quenching, leading to an enhanced NIR emission in the aggregate/solid state, which was rarely observed for BODIPY dyes. Nanoparticles of the fluorophores formed by the assembly with the polymeric surfactant F127 were successfully used for bioimaging of living cells and for tumour-targeted imaging in a tumour-bearing mouse model.

SELECTION OF CITATIONS
SEARCH DETAIL